CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade Estadual Paulista (UNESP). Campus de Botucatu. Faculdade de Medicina (FMB) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Graduate at Medicine from Universidade Estadual Paulista Júlio de Mesquita Filho. Has experience in gastroenterology and hepatology and has Doctorade in Internal Medicine Phisiopathology. Works as Post-Graduation professor in the course of Internal Medicine Phisiopathology. Has especialist title of Gastroenterologist and is a member of Brazilian Society of Hepatology. Works as associate professor of Gastroenterology at Botucatu Medical School, in which he is advisor in two postgraduate courses: Internal Medicine Phisiopathology and Clinical Research. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Background: Bisphosphonates are the mainstay of osteoporosis treatment, but their use for patients with esophageal varices has been avoided due to the risk of esophagitis, which may cause variceal bleeding. Since most clinical trials assessing osteoporosis treatment last 2 to 3 years, this study aimed to evaluate a two-year risedronate treatment for patients with esophageal varices and li…
The incidence and prevalence of hepatocellular carcinoma (HCC) is growing worldwide, leading to high mortality rates. The disease occurs mainly in cirrhotic patients, and the cure can be reached only when it is diagnosed early or when the tumor is submitted to adjuvant therapies to reduce the tumor size, being the transarterial chemoembolization (TACE) the most used approach to achieve th…
Osteoporosis is the only complication of liver cirrhosis that persists even after liver transplantation. It is a common complication among cirrhotic patients, increasing the risk of fractures and thus affecting morbidity and mortality rates. Early diagnosis and proper treatment are needed to avoid fractures and disability. The treatment requires nutritional supplementation of calcium and …
(Only some records are available in English at this moment)
Introduction: Ascites is the most common complication of cirrhosis, occurring in more than half of patients over their lifetime. Treatment involves a low-sodium diet and diuretics, but approximately 10% of patients develop refractory ascites and require large-volume paracentesis. These patients often report loss of appetite and early satiety due to abdominal fluid accumulation, which redu…
Cholelithiasis is the most common biliary disease, affecting approximately 20% of the world's population. It is prevalent in obese individuals, women and elderly people, but has increased in adults aged 20 to 40 years due to lifestyle changes and genetic factors. A specific cause of symptomatic cholelithiasis in young patients is LPAC syndrome (low-phospholipid associated cholelithiasis),…
Cirrhosis is a serious disease that usually remains asymptomatic until decompensating events, which occurs after development of portal hypertension. Among these events, one of the most serious is upper gastrointestinal bleeding (UGIB), an emergency that causes hematemesis, melena and/or hematochezia. UGIB incidence is up to 25%-40% among these patients, with mortality reaching up to 30% …
Introduction: Gallstone disease is a huge health problem that tends to growth with the increasein obesity, overweight and other risk factors such as sedentary lifestyle and Western diet. Oneof the less common causes is low phospholipids associated cholelithiasis (LPAC), caused by agenetic mutation and diagnosed by the presence of at least two of three criteria: symptomaticcholelithiasis b…
Introduction: Ascites is the most common complication of cirrhosis, and it is estimated that more than half of such patients will have ascites at some time in their lives. Low-sodium diet and diuretics are the mainstay treatments, but in 10% of cases the ascites turns out refractory and the patient begin to be submitted to large-volume paracentesis. A relevant complaint of these patients …
Liver cirrhosis is a chronic and prevalent liver disease, with high mortality that is difficult to predict, which can lead to serious complications such as esophageal varices,ascites, hepatic encephalopathy and hepatocellular carcinoma. Currently, the Child-Pugh and MELD scores are the most important prognostic predictors for patientswith liver cirrhosis. Recently, a new predictor of mort…
(Only some records are available in English at this moment)